Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer.
Saved in:
| Title: | Optimal timing for prediction of pathologic complete response to neoadjuvant chemoradiotherapy with diffusion-weighted MRI in patients with esophageal cancer. |
|---|---|
| Authors: | Borggreve, Alicia S.1,2 (AUTHOR) A.S.Borggreve@umcutrecht.nl, Heethuis, Sophie E.1 (AUTHOR), Boekhoff, Mick R.1 (AUTHOR), Goense, Lucas1,2 (AUTHOR), van Rossum, Peter S. N.1 (AUTHOR), Brosens, Lodewijk A. A.3 (AUTHOR), van Lier, Astrid L. H. M. W.1 (AUTHOR), van Hillegersberg, Richard2 (AUTHOR), Lagendijk, Jan J. W.1 (AUTHOR), Mook, Stella1 (AUTHOR), Ruurda, Jelle P.2 (AUTHOR), Meijer, Gert J.1 (AUTHOR) G.J.Meijer@umcutrecht.nl |
| Source: | European Radiology. Apr2020, Vol. 30 Issue 4, p1896-1907. 12p. 1 Diagram, 3 Charts, 3 Graphs. |
| Subjects: | Esophageal cancer, Diffusion magnetic resonance imaging, Chemoradiotherapy, Cancer radiotherapy, Cancer patients, Squamous cell carcinoma, Antineoplastic agents, Adenocarcinoma, Esophagus, Carboplatin, Anthropometry, Time, Magnetic resonance imaging, Prognosis, Treatment effectiveness, Combined modality therapy, Paclitaxel, Esophageal tumors, Longitudinal method |
| Abstract: | |
| Copyright of European Radiology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!